nach oben

Reactions Weekly

Erschienen in:

01.11.2021 | Case report

Adalimumab

Injection site reaction and rebound effect of lupus miliaris disseminatus faciei following an off-label treatment: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Alexanian C, et al. Immune profiling of lupus miliaris disseminatus faciei and successful management with anti-tumour necrosis factor therapy. Clinical and Experimental Dermatology 46: 910-914, No. 5, Jul 2021. Available from: URL: http://doi.org/10.1111/ced.14684

Titel: Adalimumab
Injection site reaction and rebound effect of lupus miliaris disseminatus faciei following an off-label treatment: case report
Publikationsdatum: 01.11.2021
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-05492-3

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Multiple drugs

Tacrolimus

Acetic-acid misuse

Nifuratel

Antivirals/varicella zoster virus vaccine live

Linezolid/protionamide/pyrazinamide